Reducing Barriers to Drug Abuse Treatment Services (RBP)

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Wright State University
ClinicalTrials.gov Identifier:
NCT00273845
First received: January 5, 2006
Last updated: February 23, 2009
Last verified: February 2009
  Purpose

The broad goal of this study is to assess the effectiveness of two interventions to facilitate treatment linkage and treatment engagement. "Treatment linkage" is operationally defined as completion of agency intake procedures and attendance at the first clinical or therapy session. "Treatment engagement" represents a more comprehensive conceptualization of "treatment retention" and includes measures of the clinical and ancillary services actually received by the client over time; as such, client engagement focuses on the intensity and duration of treatment participation. This study will enhance the CIU concept by conducting a controlled trial, using a three-armed research design, of interventions designed to enhance treatment linkage and treatment engagement. These interventions - a Motivational Intervention and Strengths-Based Case Management - are science-based and have demonstrated efficacy in moving drug abusers towards treatment and supporting treatment engagement.


Condition Intervention Phase
Substance Abuse
Behavioral: Motivational interviewing
Behavioral: Strengths-Based Case Management
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Reducing Barriers to Drug Abuse Treatment Services

Further study details as provided by Wright State University:

Primary Outcome Measures:
  • Linkage and Retention in substance abuse treatment [ Time Frame: 3 months, 6 months ] [ Designated as safety issue: No ]

Enrollment: 678
Study Start Date: May 2003
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
One session of motivational interviewing
Behavioral: Motivational interviewing
One session
Experimental: 2
Five sessions of strengths-based case management
Behavioral: Strengths-Based Case Management
5 sessions

Detailed Description:

The Specific Aims of the project are:

  1. To conduct a detailed qualitative/ethnographic investigation to study: (a) the processes and factors operant in a person's decision to link with a substance abuse treatment agency once a formal (i.e., professional) assessment and referral have been made; and (b) the processes and factors operant in staying in treatment once it has been initiated.
  2. To identify and classify, using quantitative methods, the operant barriers to treatment linkage and engagement. We will assess the factors that are associated with these barriers and examine the effects of the study's interventions on removing them.
  3. To evaluate the effectiveness, using a controlled trial, of a Motivational Intervention and Strengths-Based Case Management, compared to the CIU's "standard" referral process, by examining differences between the Standard, Motivational Intervention, and Case Management conditions on treatment linkage and engagement outcomes. The conceptual framework for this controlled trial is the well-studied Andersen model of access and health service use, modified for chemical dependency services (Andersen, 1995). The interventions are designed to affect mutable factors such as perceived barriers to treatment. Data will be collected at baseline, and at 3 and 6 months thereafter. Analyses will examine whether the interventions work better with different groups of clients (e.g. cocaine users versus marijuana users, males versus females, different ethnicities, etc); as well as different treatment modalities (standard outpatient versus intensive outpatient.)
  4. To conduct a quantitative investigation of the effects of Individual Level and Health Care System Level factors that predict treatment linkage and engagement in the context of the proposed interventions. This study component will develop comprehensive models to predict how these factors interact with the study's interventions to effect treatment linkage and treatment engagement.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • substance abuse or dependence per DSM-IVR criteria

Exclusion Criteria:

  • active thought disorder
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00273845

Locations
United States, Ohio
Samaritan CrisisCare
Dayton, Ohio, United States, 45345
Sponsors and Collaborators
Wright State University
Investigators
Principal Investigator: Richard C Rapp, M.S.W. Boonshoft School of Medicine, Wright State University
  More Information

No publications provided

Responsible Party: Marianne Shreck, Wright State University
ClinicalTrials.gov Identifier: NCT00273845     History of Changes
Other Study ID Numbers: 02-407-10, 1R01DA15690, HSP 2527
Study First Received: January 5, 2006
Last Updated: February 23, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Wright State University:
case management
substance abuse treatment
linkage

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 17, 2014